and Colorectal Cancer: A Review

Overview

Journal World J Gastrointest Oncol

Publisher Baishideng Publishing Group

Date 2018 Mar 23

PMID 29564037

Citations 140

Authors

Fu-Mei Shang

Hong-Li Liu

Affiliations

Soon will be listed here.

Abstract

() is a Gram-negative obligate anaerobe bacterium in the oral cavity and plays a role in several oral diseases, including periodontitis and gingivitis. Recently, several studies have reported that the level of is significantly elevated in human colorectal adenomas and carcinomas compared to that in adjacent normal tissue. Several researchers have also demonstrated that is obviously associated with colorectal cancer and promotes the development of colorectal neoplasms. In this review, we have summarized the recent reports on and its role in colorectal cancer and have highlighted the methods of detecting in colorectal cancer, the underlying mechanisms of pathogenesis, immunity status, and colorectal cancer prevention strategies that target .

Citing Articles

Biofilm-associated proteins: from the gut biofilms to neurodegeneration.

Valle J Gut Microbes. 2025; 17(1):2461721.

PMID: 39898557 PMC: 11792866. DOI: 10.1080/19490976.2025.2461721.

A Novel Bacteriophage with the Potential to Inhibit -Induced Proliferation of Colorectal Cancer Cells.

Lam H, Lai M, Wang P, Wu W, Chen L, Fan H Antibiotics (Basel). 2025; 14(1).

PMID: 39858331 PMC: 11760851. DOI: 10.3390/antibiotics14010045.

FadA antigen of Fusobacterium nucleatum: implications for ceRNA network in colorectal cancer and adenomatous polyps progression.

Rezasoltani S, Shams E, Piroozkhah M, Aidi Y, Azizmohammad Looha M, Bagheri P Discov Oncol. 2025; 16(1):58.

PMID: 39826054 PMC: 11741970. DOI: 10.1007/s12672-025-01796-w.

Microbiome Differences in Colorectal Cancer Patients and Healthy Individuals: Implications for Vaccine Antigen Discovery.

Ibeanu G, Rowaiye A, Okoli J, Eze D Immunotargets Ther. 2024; 13:749-774.

PMID: 39698218 PMC: 11652712. DOI: 10.2147/ITT.S486731.

A gut-derived produces the novel nisin variant designated nisin G and inhibits in a model of the human distal colon microbiome.

Lawrence G, Garcia-Gutierrez E, OMahony A, Walsh C, OConnor P, Begley M mBio. 2024; 16(2):e0157324.

PMID: 39692472 PMC: 11796361. DOI: 10.1128/mbio.01573-24.

References

Rubinstein M, Wang X, Liu W, Hao Y, Cai G, Han Y . Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. Cell Host Microbe. 2013; 14(2):195-206. PMC: 3770529. DOI: 10.1016/j.chom.2013.07.012. View

Mima K, Sukawa Y, Nishihara R, Qian Z, Yamauchi M, Inamura K . Fusobacterium nucleatum and T Cells in Colorectal Carcinoma. JAMA Oncol. 2015; 1(5):653-61. PMC: 4537376. DOI: 10.1001/jamaoncol.2015.1377. View

Mira-Pascual L, Cabrera-Rubio R, Ocon S, Costales P, Parra A, Suarez A . Microbial mucosal colonic shifts associated with the development of colorectal cancer reveal the presence of different bacterial and archaeal biomarkers. J Gastroenterol. 2014; 50(2):167-79. DOI: 10.1007/s00535-014-0963-x. View

Mehta R, Nishihara R, Cao Y, Song M, Mima K, Qian Z . Association of Dietary Patterns With Risk of Colorectal Cancer Subtypes Classified by Fusobacterium nucleatum in Tumor Tissue. JAMA Oncol. 2017; 3(7):921-927. PMC: 5502000. DOI: 10.1001/jamaoncol.2016.6374. View

Jobin C . Colorectal cancer: looking for answers in the microbiota. Cancer Discov. 2013; 3(4):384-7. PMC: 3625977. DOI: 10.1158/2159-8290.CD-13-0042. View

Binder Gallimidi A, Fischman S, Revach B, Bulvik R, Maliutina A, Rubinstein A . Periodontal pathogens Porphyromonas gingivalis and Fusobacterium nucleatum promote tumor progression in an oral-specific chemical carcinogenesis model. Oncotarget. 2015; 6(26):22613-23. PMC: 4673186. DOI: 10.18632/oncotarget.4209. View

Shenker B, Datar S . Fusobacterium nucleatum inhibits human T-cell activation by arresting cells in the mid-G1 phase of the cell cycle. Infect Immun. 1995; 63(12):4830-6. PMC: 173692. DOI: 10.1128/iai.63.12.4830-4836.1995. View

Cerwenka A, Lanier L . Natural killer cell memory in infection, inflammation and cancer. Nat Rev Immunol. 2016; 16(2):112-23. DOI: 10.1038/nri.2015.9. View

Tsai C, Chiu C, Rayner C, Wu K, Chiu Y, Hu M . Associated factors in Streptococcus bovis bacteremia and colorectal cancer. Kaohsiung J Med Sci. 2016; 32(4):196-200. DOI: 10.1016/j.kjms.2016.03.003. View

10.

Josefowicz S, Lu L, Rudensky A . Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol. 2012; 30:531-64. PMC: 6066374. DOI: 10.1146/annurev.immunol.25.022106.141623. View

11.

Sun H, Zhou X, Xue Y, Wang K, Shen Y, Mao J . Increased frequency and clinical significance of myeloid-derived suppressor cells in human colorectal carcinoma. World J Gastroenterol. 2012; 18(25):3303-9. PMC: 3391769. DOI: 10.3748/wjg.v18.i25.3303. View

12.

Nedaeinia R, Sharifi M, Avan A, Kazemi M, Nabinejad A, Ferns G . Inhibition of microRNA-21 via locked nucleic acid-anti-miR suppressed metastatic features of colorectal cancer cells through modulation of programmed cell death 4. Tumour Biol. 2017; 39(3):1010428317692261. DOI: 10.1177/1010428317692261. View

13.

Krishnan S, Eslick G . Streptococcus bovis infection and colorectal neoplasia: a meta-analysis. Colorectal Dis. 2014; 16(9):672-80. DOI: 10.1111/codi.12662. View

14.

Han Y, Shi W, Huang G, Haake S, Park N, Kuramitsu H . Interactions between periodontal bacteria and human oral epithelial cells: Fusobacterium nucleatum adheres to and invades epithelial cells. Infect Immun. 2000; 68(6):3140-6. PMC: 97547. DOI: 10.1128/IAI.68.6.3140-3146.2000. View

15.

Yang Y, Weng W, Peng J, Hong L, Yang L, Toiyama Y . Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21. Gastroenterology. 2016; 152(4):851-866.e24. PMC: 5555435. DOI: 10.1053/j.gastro.2016.11.018. View

16.

Wong S, Kwong T, Chow T, Luk A, Dai R, Nakatsu G . Quantitation of faecal improves faecal immunochemical test in detecting advanced colorectal neoplasia. Gut. 2016; 66(8):1441-1448. PMC: 5530471. DOI: 10.1136/gutjnl-2016-312766. View

17.

Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pages C . Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science. 2006; 313(5795):1960-4. DOI: 10.1126/science.1129139. View

18.

Xu J, Gordon J . Honor thy symbionts. Proc Natl Acad Sci U S A. 2003; 100(18):10452-9. PMC: 193582. DOI: 10.1073/pnas.1734063100. View

19.

Waniczek D, Lorenc Z, Snietura M, Wesecki M, Kopec A, Muc-Wierzgon M . Tumor-Associated Macrophages and Regulatory T Cells Infiltration and the Clinical Outcome in Colorectal Cancer. Arch Immunol Ther Exp (Warsz). 2017; 65(5):445-454. PMC: 5602054. DOI: 10.1007/s00005-017-0463-9. View

20.

Yang N, Zhang Q, Li J, Yang S, Shi Q . Progression of periodontal inflammation in adolescents is associated with increased number of Porphyromonas gingivalis, Prevotella intermedia, Tannerella forsythensis, and Fusobacterium nucleatum. Int J Paediatr Dent. 2013; 24(3):226-33. DOI: 10.1111/ipd.12065. View